Bolt Biotherapeutics, Inc. Common Stock BOLT
$3.56
+6.43%
at last close
Financials (TTM)
- Revenue
- $4.70 million
- Net Income
- $-28,739,000
- Net Margin
- -611.47%
- Return on Equity
- -227.37%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 0.54
- Price / Sales
- 1.46
Over the trailing twelve months, Bolt Biotherapeutics, Inc. Common Stock generated revenue of $4.70 million and net income of $-28,739,000, a net margin of -611.47%.
At the last closing price of $3.56, BOLT trades at 1.46 times sales, with a market capitalization of $6.86 million.
Key Stats
- Last Close
- $3.56
- Market Cap
- $6.86 million
- 52-Week Range
- $3.10 – $7.20
- Average Volume
- 38K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.